Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-01-25

AUTHORS

G. Ingrosso, B. Detti, A. Fodor, S. Caini, S. Borghesi, L. Triggiani, F. Trippa, D. Russo, A. Bruni, G. Francolini, A. Lancia, L. Marinelli, N. Di Muzio, L. Livi, S. M. Magrini, E. Maranzano, D. Musio, C. Aristei, M. Valeriani

ABSTRACT

ObjectivesTo report outcomes of stereotactic body radiotherapy (SBRT) in metastatic castration-resistant prostate cancer (mCRPC) patients with oligoprogression (≤ 5 metastases) during first-line treatment with androgen receptor-targeted therapy (ARTT).Patients and methodsRetrospective multi-institutional analysis of mCRPC patients treated with SBRT to oligoprogressive lesions during ARTT. End-points were time to next-line systemic treatment (NEST), radiological progression-free survival (r-PFS) and overall survival (OS). Toxicity was registered according to Common Terminology Criteria for Adverse Events (CTCAE) v4.0. Survival analysis was performed using the Kaplan–Meier method, univariate and multivariate analysis (MVA) were performed.ResultsData from 34 patients were analyzed. Median NEST-free survival, r-PFS, and OS were 16.97, 13.47, and 38.3 months, respectively. At MVA, factors associated with worse NEST-free survival and r-PFS were polymetastatic burden at diagnosis of metastatic hormone-sensitive disease (hazard ratio [HR] 3.66, p = 0.009; HR 3.03, p = 0.034), PSA ≤ 7 ng/ml at mCRPC diagnosis (HR 0.23, p = 0.017; HR 0.19, p = 0.006) and PSADT ≤ 3 months at mCRPC diagnosis (HR 3.39, p = 0.026; HR 2.79, p = 0.037). Polymetastatic state at mHSPC diagnosis was associated with a decreased OS (HR 4.68, p = 0.029). No patient developed acute or late grade ≥ 2 toxicity.ConclusionOur results suggest that SBRT in oligoprogressive mCPRC is safe, effective and seems to prolong the efficacy of the ongoing systemic treatment positively affecting disease progression. Prospective trials are needed. More... »

PAGES

1577-1584

References to SciGraph publications

  • 2019-11-14. Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience in RADIATION ONCOLOGY
  • 2020-11-23. Diagnostic accuracies of intraoperative frozen section and permanent section examinations for histological grades during open biopsy of bone tumors in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2016-05-27. Stereotactic body radiotherapy in oligometastatic prostate cancer patients with isolated lymph nodes involvement: a two-institution experience in WORLD JOURNAL OF UROLOGY
  • 2015-03-26. 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2006-12. Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2014-10-24. Stereotactic radiotherapy for isolated nodal recurrence of prostate cancer in WORLD JOURNAL OF UROLOGY
  • 2018-03-29. Oligometastatic cancer in elderly patients: the “blitzkrieg” radiotherapy approach in AGING CLINICAL AND EXPERIMENTAL RESEARCH
  • 2019-03-11. Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study in WORLD JOURNAL OF UROLOGY
  • 2017-04-27. Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study in BRITISH JOURNAL OF CANCER
  • 2018-09-06. Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment in WORLD JOURNAL OF UROLOGY
  • 2015-09-01. 11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2016-08-25. PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2020-09-01. Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • Journal

    TITLE

    Clinical and Translational Oncology

    ISSUE

    8

    VOLUME

    23

    Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s12094-021-02553-5

    DOI

    http://dx.doi.org/10.1007/s12094-021-02553-5

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1134858827

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/33495981


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Analysis of Variance", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Androgen Receptor Antagonists", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Combined Modality Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Disease Progression", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kaplan-Meier Estimate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Targeted Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Progression-Free Survival", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prostatic Neoplasms, Castration-Resistant", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Radiosurgery", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Radiotherapy Dosage", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Retrospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Radiation Oncology Section, Department of Surgical and Biomedical Science, University of Perugia, Perugia, Italy", 
              "id": "http://www.grid.ac/institutes/grid.9027.c", 
              "name": [
                "Radiation Oncology Section, Department of Surgical and Biomedical Science, University of Perugia, Perugia, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ingrosso", 
            "givenName": "G.", 
            "id": "sg:person.01047021055.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047021055.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, A.O.U Careggi, University of Florence, Florence, Italy", 
              "id": "http://www.grid.ac/institutes/grid.8404.8", 
              "name": [
                "Department of Radiation Oncology, A.O.U Careggi, University of Florence, Florence, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Detti", 
            "givenName": "B.", 
            "id": "sg:person.01232310023.88", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01232310023.88"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy", 
              "id": "http://www.grid.ac/institutes/grid.18887.3e", 
              "name": [
                "Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fodor", 
            "givenName": "A.", 
            "id": "sg:person.01363312224.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363312224.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Networking, Florence, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Networking, Florence, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Caini", 
            "givenName": "S.", 
            "id": "sg:person.01161605365.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161605365.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unit of Radiation Oncology, S. Donato Hospital, Arezzo, Italy", 
              "id": "http://www.grid.ac/institutes/grid.416351.4", 
              "name": [
                "Unit of Radiation Oncology, S. Donato Hospital, Arezzo, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Borghesi", 
            "givenName": "S.", 
            "id": "sg:person.0703604422.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703604422.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy", 
              "id": "http://www.grid.ac/institutes/grid.412725.7", 
              "name": [
                "Department of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Triggiani", 
            "givenName": "L.", 
            "id": "sg:person.01303071254.58", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303071254.58"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, \u2018S. Maria\u2019 Hospital, Terni, Italy", 
              "id": "http://www.grid.ac/institutes/grid.416377.0", 
              "name": [
                "Department of Radiation Oncology, \u2018S. Maria\u2019 Hospital, Terni, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Trippa", 
            "givenName": "F.", 
            "id": "sg:person.0602663621.04", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602663621.04"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Radiotherapy Unit, Ospedale \u201cVito Fazzi\u201d, Lecce, Italy", 
              "id": "http://www.grid.ac/institutes/grid.417011.2", 
              "name": [
                "Radiotherapy Unit, Ospedale \u201cVito Fazzi\u201d, Lecce, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Russo", 
            "givenName": "D.", 
            "id": "sg:person.010533235665.65", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010533235665.65"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Radiotherapy Unit, University Hospital of Modena, Modena, Italy", 
              "id": "http://www.grid.ac/institutes/grid.413363.0", 
              "name": [
                "Radiotherapy Unit, University Hospital of Modena, Modena, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bruni", 
            "givenName": "A.", 
            "id": "sg:person.01350726021.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350726021.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, A.O.U Careggi, University of Florence, Florence, Italy", 
              "id": "http://www.grid.ac/institutes/grid.8404.8", 
              "name": [
                "Department of Radiation Oncology, A.O.U Careggi, University of Florence, Florence, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Francolini", 
            "givenName": "G.", 
            "id": "sg:person.01233044712.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233044712.46"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy", 
              "id": "http://www.grid.ac/institutes/grid.419425.f", 
              "name": [
                "Department of Radiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lancia", 
            "givenName": "A.", 
            "id": "sg:person.01107171377.55", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107171377.55"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine and Surgery and Translational Medicine, \u201cSapienza\u201d University of Rome, Radiotherapy Oncology Operative Unit, St Andrea Hospital, Rome, Italy", 
              "id": "http://www.grid.ac/institutes/grid.7841.a", 
              "name": [
                "Department of Medicine and Surgery and Translational Medicine, \u201cSapienza\u201d University of Rome, Radiotherapy Oncology Operative Unit, St Andrea Hospital, Rome, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Marinelli", 
            "givenName": "L.", 
            "id": "sg:person.016355300165.94", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016355300165.94"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy", 
              "id": "http://www.grid.ac/institutes/grid.18887.3e", 
              "name": [
                "Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Di Muzio", 
            "givenName": "N.", 
            "id": "sg:person.0653510157.51", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653510157.51"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, A.O.U Careggi, University of Florence, Florence, Italy", 
              "id": "http://www.grid.ac/institutes/grid.8404.8", 
              "name": [
                "Department of Radiation Oncology, A.O.U Careggi, University of Florence, Florence, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Livi", 
            "givenName": "L.", 
            "id": "sg:person.0630634045.23", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630634045.23"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy", 
              "id": "http://www.grid.ac/institutes/grid.412725.7", 
              "name": [
                "Department of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Magrini", 
            "givenName": "S. M.", 
            "id": "sg:person.01113626375.68", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113626375.68"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, \u2018S. Maria\u2019 Hospital, Terni, Italy", 
              "id": "http://www.grid.ac/institutes/grid.416377.0", 
              "name": [
                "Department of Radiation Oncology, \u2018S. Maria\u2019 Hospital, Terni, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Maranzano", 
            "givenName": "E.", 
            "id": "sg:person.01317666251.26", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317666251.26"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Radiotherapy Unit, Ospedale \u201cVito Fazzi\u201d, Lecce, Italy", 
              "id": "http://www.grid.ac/institutes/grid.417011.2", 
              "name": [
                "Radiotherapy Unit, Ospedale \u201cVito Fazzi\u201d, Lecce, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Musio", 
            "givenName": "D.", 
            "id": "sg:person.01270452745.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270452745.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Radiation Oncology Section, Department of Surgical and Biomedical Science, University of Perugia, Perugia, Italy", 
              "id": "http://www.grid.ac/institutes/grid.9027.c", 
              "name": [
                "Radiation Oncology Section, Department of Surgical and Biomedical Science, University of Perugia, Perugia, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Aristei", 
            "givenName": "C.", 
            "id": "sg:person.0642375351.81", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642375351.81"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine and Surgery and Translational Medicine, \u201cSapienza\u201d University of Rome, Radiotherapy Oncology Operative Unit, St Andrea Hospital, Rome, Italy", 
              "id": "http://www.grid.ac/institutes/grid.7841.a", 
              "name": [
                "Department of Medicine and Surgery and Translational Medicine, \u201cSapienza\u201d University of Rome, Radiotherapy Oncology Operative Unit, St Andrea Hospital, Rome, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Valeriani", 
            "givenName": "M.", 
            "id": "sg:person.01213542366.06", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213542366.06"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s00259-016-3493-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016772238", 
              "https://doi.org/10.1007/s00259-016-3493-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00345-018-2477-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1106803662", 
              "https://doi.org/10.1007/s00345-018-2477-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10147-020-01836-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1132846224", 
              "https://doi.org/10.1007/s10147-020-01836-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13014-019-1414-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1122589027", 
              "https://doi.org/10.1186/s13014-019-1414-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00345-014-1427-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025002416", 
              "https://doi.org/10.1007/s00345-014-1427-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10147-020-01776-w", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1130502348", 
              "https://doi.org/10.1007/s10147-020-01776-w"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ncponc0664", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028958751", 
              "https://doi.org/10.1038/ncponc0664"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-015-3042-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033445050", 
              "https://doi.org/10.1007/s00259-015-3042-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.2017.103", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1085076985", 
              "https://doi.org/10.1038/bjc.2017.103"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-015-3177-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027307827", 
              "https://doi.org/10.1007/s00259-015-3177-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00345-016-1860-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034505009", 
              "https://doi.org/10.1007/s00345-016-1860-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s40520-018-0937-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1101838562", 
              "https://doi.org/10.1007/s40520-018-0937-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00345-019-02717-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1112683168", 
              "https://doi.org/10.1007/s00345-019-02717-7"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2021-01-25", 
        "datePublishedReg": "2021-01-25", 
        "description": "ObjectivesTo report outcomes of stereotactic body radiotherapy (SBRT) in metastatic castration-resistant prostate cancer (mCRPC) patients with oligoprogression (\u2264\u20095 metastases) during first-line treatment with androgen receptor-targeted therapy (ARTT).Patients and methodsRetrospective multi-institutional analysis of mCRPC patients treated with SBRT to oligoprogressive lesions during ARTT. End-points were time to next-line systemic treatment (NEST), radiological progression-free survival (r-PFS) and overall survival (OS). Toxicity was registered according to Common Terminology Criteria for Adverse Events (CTCAE) v4.0. Survival analysis was performed using the Kaplan\u2013Meier method, univariate and multivariate analysis (MVA) were performed.ResultsData from 34 patients were analyzed. Median NEST-free survival, r-PFS, and OS were 16.97, 13.47, and 38.3\u00a0months, respectively. At MVA, factors associated with worse NEST-free survival and r-PFS were polymetastatic burden at diagnosis of metastatic hormone-sensitive disease (hazard ratio [HR] 3.66, p\u2009=\u20090.009; HR 3.03, p\u2009=\u20090.034), PSA\u2009\u2264\u20097\u00a0ng/ml at mCRPC diagnosis (HR 0.23, p\u2009=\u20090.017; HR 0.19, p\u2009=\u20090.006) and PSADT\u2009\u2264\u20093\u00a0months at mCRPC diagnosis (HR 3.39, p\u2009=\u20090.026; HR 2.79, p\u2009=\u20090.037). Polymetastatic state at mHSPC diagnosis was associated with a decreased OS (HR 4.68, p\u2009=\u20090.029). No patient developed acute or late grade\u2009\u2265\u20092 toxicity.ConclusionOur results suggest that SBRT in oligoprogressive mCPRC is safe, effective and seems to prolong the efficacy of the ongoing systemic treatment positively affecting disease progression. Prospective trials are needed.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s12094-021-02553-5", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1035367", 
            "issn": [
              "1699-048X", 
              "1699-3055"
            ], 
            "name": "Clinical and Translational Oncology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "8", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "23"
          }
        ], 
        "keywords": [
          "androgen receptor-targeted therapy", 
          "stereotactic body radiotherapy", 
          "castration-resistant prostate cancer patients", 
          "next-line systemic treatment", 
          "receptor-targeted therapy", 
          "prostate cancer patients", 
          "overall survival", 
          "r-PFS", 
          "mCRPC diagnosis", 
          "systemic treatment", 
          "cancer patients", 
          "metastatic castration-resistant prostate cancer patients", 
          "radiological progression-free survival", 
          "metastatic hormone-sensitive disease", 
          "Adverse Events v4.0", 
          "hormone-sensitive disease", 
          "ongoing systemic treatment", 
          "Common Terminology Criteria", 
          "first-line treatment", 
          "progression-free survival", 
          "Kaplan-Meier method", 
          "stereotactic ablative radiotherapy", 
          "multi-institutional analysis", 
          "oligoprogressive lesions", 
          "Terminology Criteria", 
          "mCRPC patients", 
          "decreased OS", 
          "prospective trial", 
          "ablative radiotherapy", 
          "body radiotherapy", 
          "disease progression", 
          "patients", 
          "survival analysis", 
          "ConclusionOur results", 
          "diagnosis", 
          "oligoprogression", 
          "survival", 
          "radiotherapy", 
          "therapy", 
          "treatment", 
          "late grade", 
          "months", 
          "toxicity", 
          "PSADT", 
          "ResultsData", 
          "lesions", 
          "ObjectivesTo", 
          "disease", 
          "PSA", 
          "progression", 
          "trials", 
          "univariate", 
          "efficacy", 
          "outcomes", 
          "burden", 
          "v4.0", 
          "grade", 
          "factors", 
          "criteria", 
          "analysis", 
          "MVA", 
          "time", 
          "results", 
          "method", 
          "state"
        ], 
        "name": "Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy", 
        "pagination": "1577-1584", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1134858827"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s12094-021-02553-5"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "33495981"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s12094-021-02553-5", 
          "https://app.dimensions.ai/details/publication/pub.1134858827"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-10T10:26", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_878.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s12094-021-02553-5"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12094-021-02553-5'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12094-021-02553-5'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12094-021-02553-5'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12094-021-02553-5'


     

    This table displays all metadata directly associated to this object as RDF triples.

    403 TRIPLES      22 PREDICATES      121 URIs      99 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s12094-021-02553-5 schema:about N018bf327285343dbad307e7f2a0186ce
    2 N07aaae359fb2404bb42992874f408983
    3 N0e5709adfea8419f8536afb6e33132cf
    4 N27da1a2c145f4761996bc917e2464447
    5 N5107fefd7b04439f9a569a0b21bdeecc
    6 N990987c127a44a0f9d7eba075b91a446
    7 Nb5e03f7139d243e8970cae1a7faada68
    8 Nbbff24225f1c4d0e9cac5552aca50a0d
    9 Nbeb4360be3e34f098522f488834c7549
    10 Ncfb061a5b63d43d4adf35dea5d00edaa
    11 Nda8a0ca40427467c9654b811a211fca3
    12 Ne9bbf6d484ed4943a9bcdc8bc0ff6d5a
    13 Nef22a8e6f10a46bca1215d203465adff
    14 Nfbf665abab8946f5b375ef9c49994ae2
    15 Nfdff88896f4f4b58bdf5f5c83f4a1aff
    16 Nfffda856fb8c430eb807356d40a32d85
    17 anzsrc-for:11
    18 anzsrc-for:1103
    19 anzsrc-for:1112
    20 schema:author N4f533291380b4543b84816967898523f
    21 schema:citation sg:pub.10.1007/s00259-015-3042-5
    22 sg:pub.10.1007/s00259-015-3177-4
    23 sg:pub.10.1007/s00259-016-3493-3
    24 sg:pub.10.1007/s00345-014-1427-x
    25 sg:pub.10.1007/s00345-016-1860-0
    26 sg:pub.10.1007/s00345-018-2477-2
    27 sg:pub.10.1007/s00345-019-02717-7
    28 sg:pub.10.1007/s10147-020-01776-w
    29 sg:pub.10.1007/s10147-020-01836-1
    30 sg:pub.10.1007/s40520-018-0937-6
    31 sg:pub.10.1038/bjc.2017.103
    32 sg:pub.10.1038/ncponc0664
    33 sg:pub.10.1186/s13014-019-1414-x
    34 schema:datePublished 2021-01-25
    35 schema:datePublishedReg 2021-01-25
    36 schema:description ObjectivesTo report outcomes of stereotactic body radiotherapy (SBRT) in metastatic castration-resistant prostate cancer (mCRPC) patients with oligoprogression (≤ 5 metastases) during first-line treatment with androgen receptor-targeted therapy (ARTT).Patients and methodsRetrospective multi-institutional analysis of mCRPC patients treated with SBRT to oligoprogressive lesions during ARTT. End-points were time to next-line systemic treatment (NEST), radiological progression-free survival (r-PFS) and overall survival (OS). Toxicity was registered according to Common Terminology Criteria for Adverse Events (CTCAE) v4.0. Survival analysis was performed using the Kaplan–Meier method, univariate and multivariate analysis (MVA) were performed.ResultsData from 34 patients were analyzed. Median NEST-free survival, r-PFS, and OS were 16.97, 13.47, and 38.3 months, respectively. At MVA, factors associated with worse NEST-free survival and r-PFS were polymetastatic burden at diagnosis of metastatic hormone-sensitive disease (hazard ratio [HR] 3.66, p = 0.009; HR 3.03, p = 0.034), PSA ≤ 7 ng/ml at mCRPC diagnosis (HR 0.23, p = 0.017; HR 0.19, p = 0.006) and PSADT ≤ 3 months at mCRPC diagnosis (HR 3.39, p = 0.026; HR 2.79, p = 0.037). Polymetastatic state at mHSPC diagnosis was associated with a decreased OS (HR 4.68, p = 0.029). No patient developed acute or late grade ≥ 2 toxicity.ConclusionOur results suggest that SBRT in oligoprogressive mCPRC is safe, effective and seems to prolong the efficacy of the ongoing systemic treatment positively affecting disease progression. Prospective trials are needed.
    37 schema:genre article
    38 schema:inLanguage en
    39 schema:isAccessibleForFree false
    40 schema:isPartOf N00ce5deeb8ee47c191783b79f6166055
    41 N5d3cd1d90f1f483aa90874577cbe5d7c
    42 sg:journal.1035367
    43 schema:keywords Adverse Events v4.0
    44 Common Terminology Criteria
    45 ConclusionOur results
    46 Kaplan-Meier method
    47 MVA
    48 ObjectivesTo
    49 PSA
    50 PSADT
    51 ResultsData
    52 Terminology Criteria
    53 ablative radiotherapy
    54 analysis
    55 androgen receptor-targeted therapy
    56 body radiotherapy
    57 burden
    58 cancer patients
    59 castration-resistant prostate cancer patients
    60 criteria
    61 decreased OS
    62 diagnosis
    63 disease
    64 disease progression
    65 efficacy
    66 factors
    67 first-line treatment
    68 grade
    69 hormone-sensitive disease
    70 late grade
    71 lesions
    72 mCRPC diagnosis
    73 mCRPC patients
    74 metastatic castration-resistant prostate cancer patients
    75 metastatic hormone-sensitive disease
    76 method
    77 months
    78 multi-institutional analysis
    79 next-line systemic treatment
    80 oligoprogression
    81 oligoprogressive lesions
    82 ongoing systemic treatment
    83 outcomes
    84 overall survival
    85 patients
    86 progression
    87 progression-free survival
    88 prospective trial
    89 prostate cancer patients
    90 r-PFS
    91 radiological progression-free survival
    92 radiotherapy
    93 receptor-targeted therapy
    94 results
    95 state
    96 stereotactic ablative radiotherapy
    97 stereotactic body radiotherapy
    98 survival
    99 survival analysis
    100 systemic treatment
    101 therapy
    102 time
    103 toxicity
    104 treatment
    105 trials
    106 univariate
    107 v4.0
    108 schema:name Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy
    109 schema:pagination 1577-1584
    110 schema:productId N041b2f9ce517493f9ef72a726c54e92a
    111 N6792c53a93804e4ea195d593da12dfef
    112 Ne705ba50d0a340d1bc46aac8679d36eb
    113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1134858827
    114 https://doi.org/10.1007/s12094-021-02553-5
    115 schema:sdDatePublished 2022-05-10T10:26
    116 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    117 schema:sdPublisher Nb47201aaa9e7403b9e52d9576e299677
    118 schema:url https://doi.org/10.1007/s12094-021-02553-5
    119 sgo:license sg:explorer/license/
    120 sgo:sdDataset articles
    121 rdf:type schema:ScholarlyArticle
    122 N0079788cfadf42078b390eb7eb3a0564 rdf:first sg:person.01317666251.26
    123 rdf:rest N0a6c464b13e84168b8cdf2b0228e57af
    124 N00ce5deeb8ee47c191783b79f6166055 schema:volumeNumber 23
    125 rdf:type schema:PublicationVolume
    126 N018bf327285343dbad307e7f2a0186ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Treatment Outcome
    128 rdf:type schema:DefinedTerm
    129 N041b2f9ce517493f9ef72a726c54e92a schema:name dimensions_id
    130 schema:value pub.1134858827
    131 rdf:type schema:PropertyValue
    132 N07aaae359fb2404bb42992874f408983 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    133 schema:name Radiosurgery
    134 rdf:type schema:DefinedTerm
    135 N0a6c464b13e84168b8cdf2b0228e57af rdf:first sg:person.01270452745.50
    136 rdf:rest Ndd5e3b606efc492b9293e604f6272365
    137 N0e5709adfea8419f8536afb6e33132cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Kaplan-Meier Estimate
    139 rdf:type schema:DefinedTerm
    140 N0eea23a6c6f045468c87930776de9c54 rdf:first sg:person.01233044712.46
    141 rdf:rest Nabe92e2b77f7494e932720fc4d3f3eee
    142 N27da1a2c145f4761996bc917e2464447 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    143 schema:name Aged
    144 rdf:type schema:DefinedTerm
    145 N36f95d1203b7405ba360ee6b82a4b015 rdf:first sg:person.01363312224.44
    146 rdf:rest Ndb2245f26f724e83b717269b51ef2f31
    147 N4f533291380b4543b84816967898523f rdf:first sg:person.01047021055.47
    148 rdf:rest N65acd78653524399bd62c4d013c6dd34
    149 N5107fefd7b04439f9a569a0b21bdeecc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Radiotherapy Dosage
    151 rdf:type schema:DefinedTerm
    152 N53b7d35a93874905ba7e3cfc214e77e6 rdf:first sg:person.0630634045.23
    153 rdf:rest N7458093f518a44cfa7e70d791318de24
    154 N5d3cd1d90f1f483aa90874577cbe5d7c schema:issueNumber 8
    155 rdf:type schema:PublicationIssue
    156 N616842eab46c4e12adbe7402b6e5ff78 rdf:first sg:person.01213542366.06
    157 rdf:rest rdf:nil
    158 N63fe513c2bc84654b8c2c6b0ce0b39f1 rdf:first sg:person.0703604422.43
    159 rdf:rest N98b1ecaf90074eccbaaf8e62f7348f2f
    160 N65acd78653524399bd62c4d013c6dd34 rdf:first sg:person.01232310023.88
    161 rdf:rest N36f95d1203b7405ba360ee6b82a4b015
    162 N6792c53a93804e4ea195d593da12dfef schema:name doi
    163 schema:value 10.1007/s12094-021-02553-5
    164 rdf:type schema:PropertyValue
    165 N7458093f518a44cfa7e70d791318de24 rdf:first sg:person.01113626375.68
    166 rdf:rest N0079788cfadf42078b390eb7eb3a0564
    167 N8cece281f89b409b98bb647be97227de rdf:first sg:person.0653510157.51
    168 rdf:rest N53b7d35a93874905ba7e3cfc214e77e6
    169 N8f5a5f1479034347890b6b7b42595ded rdf:first sg:person.01350726021.50
    170 rdf:rest N0eea23a6c6f045468c87930776de9c54
    171 N98b1ecaf90074eccbaaf8e62f7348f2f rdf:first sg:person.01303071254.58
    172 rdf:rest Neb504321b03f4deb916af1befb0241a1
    173 N990987c127a44a0f9d7eba075b91a446 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Retrospective Studies
    175 rdf:type schema:DefinedTerm
    176 Nabe92e2b77f7494e932720fc4d3f3eee rdf:first sg:person.01107171377.55
    177 rdf:rest Ncc41dc58fa5e4997ab417ef5df7912af
    178 Nb47201aaa9e7403b9e52d9576e299677 schema:name Springer Nature - SN SciGraph project
    179 rdf:type schema:Organization
    180 Nb5e03f7139d243e8970cae1a7faada68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Androgen Receptor Antagonists
    182 rdf:type schema:DefinedTerm
    183 Nbbff24225f1c4d0e9cac5552aca50a0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    184 schema:name Progression-Free Survival
    185 rdf:type schema:DefinedTerm
    186 Nbeb4360be3e34f098522f488834c7549 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Prostatic Neoplasms, Castration-Resistant
    188 rdf:type schema:DefinedTerm
    189 Nbee08b7a7ede4344aad06fc0ea0572e0 rdf:first sg:person.010533235665.65
    190 rdf:rest N8f5a5f1479034347890b6b7b42595ded
    191 Ncc41dc58fa5e4997ab417ef5df7912af rdf:first sg:person.016355300165.94
    192 rdf:rest N8cece281f89b409b98bb647be97227de
    193 Ncfb061a5b63d43d4adf35dea5d00edaa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    194 schema:name Humans
    195 rdf:type schema:DefinedTerm
    196 Nda8a0ca40427467c9654b811a211fca3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    197 schema:name Male
    198 rdf:type schema:DefinedTerm
    199 Ndb2245f26f724e83b717269b51ef2f31 rdf:first sg:person.01161605365.07
    200 rdf:rest N63fe513c2bc84654b8c2c6b0ce0b39f1
    201 Ndd5e3b606efc492b9293e604f6272365 rdf:first sg:person.0642375351.81
    202 rdf:rest N616842eab46c4e12adbe7402b6e5ff78
    203 Ne705ba50d0a340d1bc46aac8679d36eb schema:name pubmed_id
    204 schema:value 33495981
    205 rdf:type schema:PropertyValue
    206 Ne9bbf6d484ed4943a9bcdc8bc0ff6d5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    207 schema:name Combined Modality Therapy
    208 rdf:type schema:DefinedTerm
    209 Neb504321b03f4deb916af1befb0241a1 rdf:first sg:person.0602663621.04
    210 rdf:rest Nbee08b7a7ede4344aad06fc0ea0572e0
    211 Nef22a8e6f10a46bca1215d203465adff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    212 schema:name Analysis of Variance
    213 rdf:type schema:DefinedTerm
    214 Nfbf665abab8946f5b375ef9c49994ae2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    215 schema:name Disease Progression
    216 rdf:type schema:DefinedTerm
    217 Nfdff88896f4f4b58bdf5f5c83f4a1aff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    218 schema:name Middle Aged
    219 rdf:type schema:DefinedTerm
    220 Nfffda856fb8c430eb807356d40a32d85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    221 schema:name Molecular Targeted Therapy
    222 rdf:type schema:DefinedTerm
    223 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    224 schema:name Medical and Health Sciences
    225 rdf:type schema:DefinedTerm
    226 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    227 schema:name Clinical Sciences
    228 rdf:type schema:DefinedTerm
    229 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    230 schema:name Oncology and Carcinogenesis
    231 rdf:type schema:DefinedTerm
    232 sg:journal.1035367 schema:issn 1699-048X
    233 1699-3055
    234 schema:name Clinical and Translational Oncology
    235 schema:publisher Springer Nature
    236 rdf:type schema:Periodical
    237 sg:person.01047021055.47 schema:affiliation grid-institutes:grid.9027.c
    238 schema:familyName Ingrosso
    239 schema:givenName G.
    240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047021055.47
    241 rdf:type schema:Person
    242 sg:person.010533235665.65 schema:affiliation grid-institutes:grid.417011.2
    243 schema:familyName Russo
    244 schema:givenName D.
    245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010533235665.65
    246 rdf:type schema:Person
    247 sg:person.01107171377.55 schema:affiliation grid-institutes:grid.419425.f
    248 schema:familyName Lancia
    249 schema:givenName A.
    250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107171377.55
    251 rdf:type schema:Person
    252 sg:person.01113626375.68 schema:affiliation grid-institutes:grid.412725.7
    253 schema:familyName Magrini
    254 schema:givenName S. M.
    255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113626375.68
    256 rdf:type schema:Person
    257 sg:person.01161605365.07 schema:affiliation grid-institutes:None
    258 schema:familyName Caini
    259 schema:givenName S.
    260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161605365.07
    261 rdf:type schema:Person
    262 sg:person.01213542366.06 schema:affiliation grid-institutes:grid.7841.a
    263 schema:familyName Valeriani
    264 schema:givenName M.
    265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213542366.06
    266 rdf:type schema:Person
    267 sg:person.01232310023.88 schema:affiliation grid-institutes:grid.8404.8
    268 schema:familyName Detti
    269 schema:givenName B.
    270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01232310023.88
    271 rdf:type schema:Person
    272 sg:person.01233044712.46 schema:affiliation grid-institutes:grid.8404.8
    273 schema:familyName Francolini
    274 schema:givenName G.
    275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233044712.46
    276 rdf:type schema:Person
    277 sg:person.01270452745.50 schema:affiliation grid-institutes:grid.417011.2
    278 schema:familyName Musio
    279 schema:givenName D.
    280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270452745.50
    281 rdf:type schema:Person
    282 sg:person.01303071254.58 schema:affiliation grid-institutes:grid.412725.7
    283 schema:familyName Triggiani
    284 schema:givenName L.
    285 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303071254.58
    286 rdf:type schema:Person
    287 sg:person.01317666251.26 schema:affiliation grid-institutes:grid.416377.0
    288 schema:familyName Maranzano
    289 schema:givenName E.
    290 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317666251.26
    291 rdf:type schema:Person
    292 sg:person.01350726021.50 schema:affiliation grid-institutes:grid.413363.0
    293 schema:familyName Bruni
    294 schema:givenName A.
    295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350726021.50
    296 rdf:type schema:Person
    297 sg:person.01363312224.44 schema:affiliation grid-institutes:grid.18887.3e
    298 schema:familyName Fodor
    299 schema:givenName A.
    300 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363312224.44
    301 rdf:type schema:Person
    302 sg:person.016355300165.94 schema:affiliation grid-institutes:grid.7841.a
    303 schema:familyName Marinelli
    304 schema:givenName L.
    305 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016355300165.94
    306 rdf:type schema:Person
    307 sg:person.0602663621.04 schema:affiliation grid-institutes:grid.416377.0
    308 schema:familyName Trippa
    309 schema:givenName F.
    310 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602663621.04
    311 rdf:type schema:Person
    312 sg:person.0630634045.23 schema:affiliation grid-institutes:grid.8404.8
    313 schema:familyName Livi
    314 schema:givenName L.
    315 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630634045.23
    316 rdf:type schema:Person
    317 sg:person.0642375351.81 schema:affiliation grid-institutes:grid.9027.c
    318 schema:familyName Aristei
    319 schema:givenName C.
    320 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642375351.81
    321 rdf:type schema:Person
    322 sg:person.0653510157.51 schema:affiliation grid-institutes:grid.18887.3e
    323 schema:familyName Di Muzio
    324 schema:givenName N.
    325 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653510157.51
    326 rdf:type schema:Person
    327 sg:person.0703604422.43 schema:affiliation grid-institutes:grid.416351.4
    328 schema:familyName Borghesi
    329 schema:givenName S.
    330 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703604422.43
    331 rdf:type schema:Person
    332 sg:pub.10.1007/s00259-015-3042-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033445050
    333 https://doi.org/10.1007/s00259-015-3042-5
    334 rdf:type schema:CreativeWork
    335 sg:pub.10.1007/s00259-015-3177-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027307827
    336 https://doi.org/10.1007/s00259-015-3177-4
    337 rdf:type schema:CreativeWork
    338 sg:pub.10.1007/s00259-016-3493-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016772238
    339 https://doi.org/10.1007/s00259-016-3493-3
    340 rdf:type schema:CreativeWork
    341 sg:pub.10.1007/s00345-014-1427-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1025002416
    342 https://doi.org/10.1007/s00345-014-1427-x
    343 rdf:type schema:CreativeWork
    344 sg:pub.10.1007/s00345-016-1860-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034505009
    345 https://doi.org/10.1007/s00345-016-1860-0
    346 rdf:type schema:CreativeWork
    347 sg:pub.10.1007/s00345-018-2477-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106803662
    348 https://doi.org/10.1007/s00345-018-2477-2
    349 rdf:type schema:CreativeWork
    350 sg:pub.10.1007/s00345-019-02717-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112683168
    351 https://doi.org/10.1007/s00345-019-02717-7
    352 rdf:type schema:CreativeWork
    353 sg:pub.10.1007/s10147-020-01776-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1130502348
    354 https://doi.org/10.1007/s10147-020-01776-w
    355 rdf:type schema:CreativeWork
    356 sg:pub.10.1007/s10147-020-01836-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1132846224
    357 https://doi.org/10.1007/s10147-020-01836-1
    358 rdf:type schema:CreativeWork
    359 sg:pub.10.1007/s40520-018-0937-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101838562
    360 https://doi.org/10.1007/s40520-018-0937-6
    361 rdf:type schema:CreativeWork
    362 sg:pub.10.1038/bjc.2017.103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085076985
    363 https://doi.org/10.1038/bjc.2017.103
    364 rdf:type schema:CreativeWork
    365 sg:pub.10.1038/ncponc0664 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028958751
    366 https://doi.org/10.1038/ncponc0664
    367 rdf:type schema:CreativeWork
    368 sg:pub.10.1186/s13014-019-1414-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1122589027
    369 https://doi.org/10.1186/s13014-019-1414-x
    370 rdf:type schema:CreativeWork
    371 grid-institutes:None schema:alternateName Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Networking, Florence, Italy
    372 schema:name Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Networking, Florence, Italy
    373 rdf:type schema:Organization
    374 grid-institutes:grid.18887.3e schema:alternateName Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy
    375 schema:name Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy
    376 rdf:type schema:Organization
    377 grid-institutes:grid.412725.7 schema:alternateName Department of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy
    378 schema:name Department of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy
    379 rdf:type schema:Organization
    380 grid-institutes:grid.413363.0 schema:alternateName Radiotherapy Unit, University Hospital of Modena, Modena, Italy
    381 schema:name Radiotherapy Unit, University Hospital of Modena, Modena, Italy
    382 rdf:type schema:Organization
    383 grid-institutes:grid.416351.4 schema:alternateName Unit of Radiation Oncology, S. Donato Hospital, Arezzo, Italy
    384 schema:name Unit of Radiation Oncology, S. Donato Hospital, Arezzo, Italy
    385 rdf:type schema:Organization
    386 grid-institutes:grid.416377.0 schema:alternateName Department of Radiation Oncology, ‘S. Maria’ Hospital, Terni, Italy
    387 schema:name Department of Radiation Oncology, ‘S. Maria’ Hospital, Terni, Italy
    388 rdf:type schema:Organization
    389 grid-institutes:grid.417011.2 schema:alternateName Radiotherapy Unit, Ospedale “Vito Fazzi”, Lecce, Italy
    390 schema:name Radiotherapy Unit, Ospedale “Vito Fazzi”, Lecce, Italy
    391 rdf:type schema:Organization
    392 grid-institutes:grid.419425.f schema:alternateName Department of Radiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
    393 schema:name Department of Radiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
    394 rdf:type schema:Organization
    395 grid-institutes:grid.7841.a schema:alternateName Department of Medicine and Surgery and Translational Medicine, “Sapienza” University of Rome, Radiotherapy Oncology Operative Unit, St Andrea Hospital, Rome, Italy
    396 schema:name Department of Medicine and Surgery and Translational Medicine, “Sapienza” University of Rome, Radiotherapy Oncology Operative Unit, St Andrea Hospital, Rome, Italy
    397 rdf:type schema:Organization
    398 grid-institutes:grid.8404.8 schema:alternateName Department of Radiation Oncology, A.O.U Careggi, University of Florence, Florence, Italy
    399 schema:name Department of Radiation Oncology, A.O.U Careggi, University of Florence, Florence, Italy
    400 rdf:type schema:Organization
    401 grid-institutes:grid.9027.c schema:alternateName Radiation Oncology Section, Department of Surgical and Biomedical Science, University of Perugia, Perugia, Italy
    402 schema:name Radiation Oncology Section, Department of Surgical and Biomedical Science, University of Perugia, Perugia, Italy
    403 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...